Vorapaxar Sulfate
| CAS No. | 705260-08-8 | Cat. No. | BCP12318 |
| Name | Vorapaxar Sulfate | ||
| Synonyms | SCH530348 Sulfate; SCH 530348 Sulfate; SCH-530348 Sulfate; | ||
| Formula | C29H35FN2O8S | M. Wt | 590.66 |
| Description | Vorapaxar, also known as SCH 530348, is a thrombin receptor (protease-activated receptor, PAR-1) antagonist based on the natural product himbacine. Discovered by Schering-Plough and currently being developed by Merck & Co., it is an experimental pharmaceutical treatment for acute coronary syndrome chest pain caused by coronary artery disease. On May 05, 2014, vorapaxar obtained FDA approval. | ||
| Pathways | GPCR/G Protein | ||
| Targets | PAR | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.